This study performed in a Mexican population indicates that comorbidities such as: T2DM, hypertension and obesity, as well as elevated levels of glucose, IL-6, LDH and CRP are associated with the COVID-19 severity. Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.